In a chilling development for healthcare systems across the United States, a dramatic increase in multidrug-resistant bacteria known as carbapenemase-producing carbapenem-resistant Enterobacterales (CP-CRE) has emerged as a formidable challenge in hospitals, often dubbed a "superbug" due to its
In the heart of New Orleans, a small HIV outreach ministry faces an impossible choice: cut essential supplies like condoms or lay off staff who keep the operation running, reflecting a broader crisis rippling across the United States in 2025. Behind closed doors, Russell Vought, director of the
In the fast-paced realm of pharmaceutical advancements, few stories capture attention like the regulatory journey of Sanofi’s tolebrutinib, a potential game-changer for non-relapsing secondary progressive multiple sclerosis (nrSPMS). This Bruton’s tyrosine kinase (BTK) inhibitor, aimed at slowing
Cardiovascular disease (CVD) stands as a formidable global health challenge, claiming roughly one-third of all deaths worldwide in 2023, according to the most extensive analysis yet from the Global Burden of Disease (GBD) Study. Spanning data across 204 countries and territories over more than
In an era where global health challenges are becoming increasingly complex and unpredictable, pharmaceutical leaders are under immense pressure to craft development programs that can endure a spectrum of uncertainties, ranging from sudden pandemics to geopolitical tensions and environmental
I'm thrilled to sit down with Dr. James Maitland, a renowned expert in maternal-fetal medicine and neurodevelopmental research at Massachusetts General Hospital. With a deep commitment to understanding how prenatal exposures impact child development, Dr. Maitland has been at the forefront of
